Princeton, NJ, United States of America

Mary Potasek

This inventor holds 1 USPTO granted patent. Top assignee: Simphotek, Inc.. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Potasek: Innovator in Photodynamic Therapy

Introduction

Mary Potasek is a notable inventor based in Princeton, NJ (US). She has made significant contributions to the field of medical technology, particularly in photodynamic therapy. Her innovative approach aims to enhance treatment methods for patients requiring targeted therapies.

Latest Patents

Mary Potasek holds a patent for her invention titled "Interstitial Photodynamic Therapy." This method involves administering interstitial photodynamic therapy to a target region of a patient. The process includes receiving information related to the target region, initial photosensitizer concentration, and various photokinetic rate parameters. The invention also determines the optimal location for inserting treatment fibers to deliver light effectively. The treatment dose is calculated based on the light fluence rate and other parameters, ensuring precise and effective therapy.

Career Highlights

Mary Potasek has established herself as a key figure in her field through her innovative work. She is currently associated with Simphotek, Inc., where she continues to develop and refine her techniques in photodynamic therapy. Her dedication to advancing medical technology has positioned her as a leader in her area of expertise.

Collaborations

Mary collaborates with Evgueni Parilov, contributing to the development of cutting-edge solutions in photodynamic therapy. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Mary Potasek's contributions to photodynamic therapy highlight her role as an influential inventor in the medical field. Her innovative methods and dedication to improving patient care continue to make a significant impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…